ANI Pharmaceuticals, Inc. (ANIP) Social Stream
ANI PHARMACEUTICALS INC (ANIP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ANI PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-20 | 3 | $70 | $50 | $61.666 | $56.13 | 9.86% |
| 2022-03-15 | 3 | $70 | $47 | $55.666 | $56.13 | -0.83% |
| 2022-08-01 | 3 | $47 | $30 | $40.666 | $56.13 | -27.55% |
| 2022-08-09 | 3 | $48 | $30 | $41 | $56.13 | -26.96% |
| 2022-11-14 | 4 | $50 | $30 | $43.25 | $56.13 | -22.95% |
| 2023-02-21 | 4 | $50 | $30 | $44.5 | $56.13 | -20.72% |
| 2023-03-09 | 5 | $55 | $30 | $46.6 | $56.13 | -16.98% |
| 2023-03-13 | 5 | $55 | $40 | $49.2 | $56.13 | -12.35% |
| 2023-05-09 | 5 | $60 | $40 | $51.2 | $56.13 | -8.78% |
| 2023-07-21 | 4 | $60 | $49 | $57 | $56.13 | 1.55% |
| 2023-07-27 | 3 | $62 | $60 | $60.666 | $56.13 | 8.08% |
| 2023-08-10 | 3 | $72 | $60 | $67.333 | $56.13 | 19.96% |
| 2023-11-09 | 3 | $73 | $70 | $71.666 | $56.13 | 27.68% |
| 2023-12-19 | 4 | $73 | $66 | $70.25 | $56.13 | 25.16% |
The Trend in the Analyst Price Target
Over the past 14 months, ANIP's average price target has gone up $27.
Over the past 50 weeks, ANIP's average upside potential has been 16.88%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-21 | 4 | 50 | 30 | 44.5 | 40.22 | 10.64% |
| 2023-03-13 | 5 | 55 | 40 | 49.2 | 41.01 | 19.97% |
| 2023-05-09 | 4 | 60 | 49 | 56.0 | 44.41 | 26.1% |
| 2023-05-09 | 5 | 60 | 42 | 52.5 | 44.41 | 18.22% |
| 2023-05-09 | 5 | 60 | 40 | 52.0 | 44.41 | 17.09% |
ANIP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
ANIP's average broker recommendation rating improved by 0.5 over the prior 15 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ANI PHARMACEUTICALS INC's number of analysts covering the stock is greater than 284.13% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ANI PHARMACEUTICALS INC's average analyst price target is higher than 2022.47% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ANI PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 276.15% of them.
- In the context of Pharmaceutical Products stocks, ANI PHARMACEUTICALS INC's variance in analysts' estimates is lower than -315.2% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ANI PHARMACEUTICALS INC are SIGA, ASRT, and NATR.
View All Top Stocks by Price Target
Is ANIP a Buy, Hold or Sell? See the POWR Ratings now!